Federal Register Notice: FDA’s Antiviral Drugs Advisory Committee will meet 4/24, from 8 a.m. to 4 p.m. at CDER’s Advisory Committee Conference Room, Rm. 1066, 5630 Fishers Lane, Rockville, MD. The committee will consider a Pfizer NDA for maraviroc 300 mg tablets proposed for treating antiretroviral-experienced patients with chemokine (c-c motif) receptor 5 (CCR5) — tropic HIV. Contact Cicely Reese, (301) 827-7001. To view this notice, click here.
